

ATSRxPodcast: The Science Behind Drug Interactions: Impact of Observational vs. Causality in Interactions Affecting Acute Care Drugs
Jun 6, 2023
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Introduction
00:00 • 3min
How I Got to Where I Am Today
03:08 • 4min
The Importance of Drug Optimization in the ICU Setting
07:26 • 3min
The Remarkable Story of Paper Cilenteso, Back to Him and Banka Myson
10:47 • 3min
The Nephrotoxic Association Between Acomycin and Piptazolentase of Backtam
13:58 • 4min
The Role of CISTAT and C in Kidney Function
18:10 • 4min
Cistern C: A Biomarker for Critical Illness
22:04 • 4min
The Effects of Bank Plus Pit TASO on System C and Creatine
25:59 • 4min
The Risk of Benzodiazepine Interactions With Other Drugs
29:42 • 3min
The Effects of Benzodiazepine on Traumatic Injury
33:09 • 2min
The Role of Drugs in Traumatic Injury
35:36 • 5min
The Importance of Causal Inference on Drug-Drug Interactions
40:13 • 2min
The Ethics of Randomized Controlled Trials
42:00 • 3min
How to Minimize Confounding by Indication in Drug Interactions
44:32 • 3min
The Immortal Time Bias
47:22 • 5min
How to Avoid Mortal Time Bias in an Observational Study
52:40 • 2min
Synergistic Nephrotoxicity in Drugs
54:12 • 7min